British Columbia Investment Management Corp Novavax Inc Transaction History

British Columbia Investment Management Corp

  • $16 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$36.28 - $75.29 $402,236 - $834,740
-11,087 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$69.73 - $142.9 $95,251 - $195,201
-1,366 Reduced 10.97%
11,087 $817,000
Q4 2021

Feb 11, 2022
SELL
$134.56 - $217.97 $77,102 - $124,896
-573 Reduced 4.4%
12,453 $1.78 Million
Q3 2021

Nov 12, 2021
SELL
$177.8 - $270.58 $13,512 - $20,564
-76 Reduced 0.58%
13,026 $2.7 Million
Q2 2021

Aug 09, 2021
BUY
$121.0 - $257.67 $1.59 Million - $3.38 Million
13,102 New
13,102 $2.78 Million

Others Institutions Holding NVAX

# of Institutions
290
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $680M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email